These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8464878)

  • 1. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
    Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.
    Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J
    J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.
    Delézay O; Koch N; Yahi N; Hammache D; Tourres C; Tamalet C; Fantini J
    AIDS; 1997 Sep; 11(11):1311-8. PubMed ID: 9302439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.
    Harouse JM; Collman RG; González-Scarano F
    J Virol; 1995 Dec; 69(12):7383-90. PubMed ID: 7494242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
    Yahi N; Sabatier JM; Baghdiguian S; Gonzalez-Scarano F; Fantini J
    J Virol; 1995 Jan; 69(1):320-5. PubMed ID: 7983725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells.
    Yahi N; Spitalnik SL; Stefano KA; De Micco P; Gonzalez-Scarano F; Fantini J
    Virology; 1994 Nov; 204(2):550-7. PubMed ID: 7941321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
    Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.
    Fantini J; Hammache D; Delézay O; Yahi N; André-Barrès C; Rico-Lattes I; Lattes A
    J Biol Chem; 1997 Mar; 272(11):7245-52. PubMed ID: 9054420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Bhat S; Spitalnik SL; Gonzalez-Scarano F; Silberberg DH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7131-4. PubMed ID: 1871126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
    Long D; Berson JF; Cook DG; Doms RW
    J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.
    Fantini J; Hammache D; Delézay O; Piéroni G; Tamalet C; Yahi N
    Virology; 1998 Jul; 246(2):211-20. PubMed ID: 9657940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
    Yahi N; Fantini J; Baghdiguian S; Mabrouk K; Tamalet C; Rochat H; Van Rietschoten J; Sabatier JM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4867-71. PubMed ID: 7761414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm.
    Brogi A; Presentini R; Solazzo D; Piomboni P; Costantino-Ceccarini E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):483-9. PubMed ID: 8679303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.
    Yahi N; Baghdiguian S; Moreau H; Fantini J
    J Virol; 1992 Aug; 66(8):4848-54. PubMed ID: 1378511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes.
    Ma M; Geiger JD; Nath A
    J Virol; 1994 Oct; 68(10):6824-8. PubMed ID: 8084022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3.
    Hammache D; Piéroni G; Yahi N; Delézay O; Koch N; Lafont H; Tamalet C; Fantini J
    J Biol Chem; 1998 Apr; 273(14):7967-71. PubMed ID: 9525894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism.
    Moses AV; Bloom FE; Pauza CD; Nelson JA
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10474-8. PubMed ID: 7504264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy.
    Dayanithi G; Yahi N; Baghdiguian S; Fantini J
    Cell Calcium; 1995 Jul; 18(1):9-18. PubMed ID: 7585886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin.
    Han Y; Ventura CL; Black KP; Cummins JE; Hall SD; Jackson S
    Oral Microbiol Immunol; 2000 Apr; 15(2):82-8. PubMed ID: 11155170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.